Indications and uses
temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion runny nose sneezing itchy nose
temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion runny nose sneezing itchy nose
Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for more than 2 weeks use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day CH...
Drug Facts
(in each spray)
Triamcinolone acetonide
55 mcg (glucocorticoid)
Allergy symptom reliever
temporarily relieves these symptoms of hay fever or other upper respiratory allergies:
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
Read insert (inside package) on how to:
| ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER | |
| adults and children 12 years of age and older |
|
| CHILDREN 2 TO UNDER 12 YEARS OF AGE | |
| |
| children 6 to under 12 years of age |
|
| children 2 to under 6 years of age |
|
| children under 2 years of age |
|
benzalkonium chloride, carboxymethylcellulose sodium, dextrose, edetate disodium, hydrochloric acid or sodium hydroxide (for pH adjustment), microcrystalline cellulose, polysorbate 80, purified water
call toll-free 1-800-633-1610
Original Prescription Strength
NDC 41167-5900-2
Multi-Symptom
Nasal Allergy Spray
Children's
Nasacort Allergy 24HR
triamcinolone acetonide nasal spray 55 mcg per spray
allergy symptom reliever
(glucocorticoid)*
60 Sprays
0.37 fl. oz. (10.8 ml)
*Triamcinolone acetonide
is a steroid medicine
known as a glucocorticoid.
Multi-Symptom
Nasal Allergy Spray
Triamcinolone acetonide nasal spray 55 mcg per spray
Allergy symptom reliever
(glucocorticoid)
Children's
Nasacort
Allergy 24HR Insert
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41167-5900-2 | ML - Milliliter | 41167-5900 | e5074a90-6824-414a-851e-cafda93d1dd3 | 1 | 2015-11-12 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TRIAMCINOLONE ACETONIDE | ACTIVE INGREDIENT | F446C597KA | 2 | |
| TRIAMCINOLONE ACETONIDE | ACTIVE MOIETY | F446C597KA | 2 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 2 | |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | INACTIVE INGREDIENT | K679OBS311 | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| DEXTROSE, UNSPECIFIED FORM | INACTIVE INGREDIENT | IY9XDZ35W2 | 2 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 2 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-5900 | 41167-5900-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TRIAMCINOLONE ACETONIDE | F446C597KA | ACTIB |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED / ORAL | 0.08 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY / NASAL | 1 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | SOLUTION / ORAL | 2489 mg/5ml | ||
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, DELAYED RELEASE / ORAL | 280 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | CONCENTRATE / ORAL | 400 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.05 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRATHECAL | ADJ PH | ||
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / INTRALESIONAL | 15 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | ADJ PH | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / SUBLINGUAL | 0.08 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SUSPENSION/ DROPS / TOPICAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | POWDER, FOR SUSPENSION / ORAL | 285 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / OPHTHALMIC | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / RECTAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAVENOUS | 4680 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / OPHTHALMIC | 0.05 %w/v | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / RECTAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION / SOFT TISSUE | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EFFERVESCENT / ORAL | 32 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION / INTRAVITREAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRA-ARTICULAR | 1 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DISC / TOPICAL | ADJ PH | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRAMUSCULAR | 1 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, COATED / ORAL | 3.2 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRADERMAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | LIQUID / INTRAVENOUS | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, COATED / ORAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / BUCCAL | 5 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TABLET, DELAYED RELEASE / ORAL | NA | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRAVENOUS | 720 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / ORAL | 206 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | GEL / OPHTHALMIC | 0.01 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 25 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | OINTMENT / TOPICAL | 0.1 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / OPHTHALMIC | 6 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SUSPENSION / INTRAMUSCULAR | 0.7 %w/v | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | PASTILLE / ORAL | 826 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAMUSCULAR | 10 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | CAPSULE / ORAL | 7 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GRANULE, FOR SUSPENSION / ORAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / ORAL | 4 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INFILTRATION | 0.37 %w/v | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SPONGE / TOPICAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION / INTRASYNOVIAL | ADJ PH | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020468-002 | NASACORT ALLERGY 24 HOUR | TRIAMCINOLONE ACETONIDE | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020468-002 | NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2013-10-11 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8028c27c-71a2-4f58-afb0-5948d92dadbf | 2683ce6a-c4d2-4d51-9bb6-d842581ebdd8 | 2022-07-29 | Warnings | 2683ce6a-c4d2-4d51-9bb6-d842581ebdd8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.